Journal of affective disorders · 2025
Users of e-Health tools for mental health and suicide primary prevention: description of their characteristics, usage, and satisfaction in the case of StopBlues.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Le Jeannic Anaïs, Michel Morgane, El Hayek Claude, Chevreul Karine, PRINTEMPS Consortium
Аннотация
BACKGROUND: Thousands of mental health (MH) applications are currently available. Suicidal behavior prevention could benefit from such tools, but few have been evaluated. StopBlues (SB) is an app- and web-based intervention for suicide primary prevention for the French general population. Our objectives were to better understand who users of e-health tools for suicide prevention are by describing SB users' characteristics and their use of the tool, engagement and satisfaction along with the factors associated with the latter two.
METHODS: Age, gender, socioeconomic status (SES), and MH were collected from users who registered to SB between March 2018 and February 2020. MH was self-assessed with validated questionnaires on global MH, depression, anxiety and suicide risk. Use of SB was assessed through functionalities users interacted with (questionnaires, moodtrackers and/or safety plan). Engagement was calculated between date of registration and last interaction with those functionalities. Satisfaction was assessed through a dedicated survey between May 2019 to June 2020. Regression models studied the factors associated with satisfaction and duration of engagement.
OUTCOMES: 10,792 people registered to SB during the study period. Two-thirds were women, mean age was was 38·5 years old (SD = 13·8), and 53·9 % lived in municipalities from the two highest SES quintiles. 47·8 % presented a risk of moderately severe or severe depression, and 27·2 % of severe anxiety. 23 % used the app for more than a day, with a mean duration engagement of 69 days (SD = 105). 96·4 % engaged at least once with either self-assessment questionnaires/moodtrackers or the safety plan, and 21·5 % interacted with both. 413 users completed the satisfaction survey and mean satisfaction was 61·6/100 (SD = 24·7).
INTERPRETATION: E-health tools for primary suicide prevention appear to be useful for users but close considerations to gender and age should be made when developing such tools.
FUNDING: French National Public Health Agency, Santé Publique France (grant 026/14).
METHODS: Age, gender, socioeconomic status (SES), and MH were collected from users who registered to SB between March 2018 and February 2020. MH was self-assessed with validated questionnaires on global MH, depression, anxiety and suicide risk. Use of SB was assessed through functionalities users interacted with (questionnaires, moodtrackers and/or safety plan). Engagement was calculated between date of registration and last interaction with those functionalities. Satisfaction was assessed through a dedicated survey between May 2019 to June 2020. Regression models studied the factors associated with satisfaction and duration of engagement.
OUTCOMES: 10,792 people registered to SB during the study period. Two-thirds were women, mean age was was 38·5 years old (SD = 13·8), and 53·9 % lived in municipalities from the two highest SES quintiles. 47·8 % presented a risk of moderately severe or severe depression, and 27·2 % of severe anxiety. 23 % used the app for more than a day, with a mean duration engagement of 69 days (SD = 105). 96·4 % engaged at least once with either self-assessment questionnaires/moodtrackers or the safety plan, and 21·5 % interacted with both. 413 users completed the satisfaction survey and mean satisfaction was 61·6/100 (SD = 24·7).
INTERPRETATION: E-health tools for primary suicide prevention appear to be useful for users but close considerations to gender and age should be made when developing such tools.
FUNDING: French National Public Health Agency, Santé Publique France (grant 026/14).